Clarity Asset Management, Inc. Sarepta Therapeutics, Inc. Transaction History
Clarity Asset Management, Inc.
- $144 Billion
- Q3 2024
A detailed history of Clarity Asset Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Clarity Asset Management, Inc. holds 25 shares of SRPT stock, worth $2,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 25
-0.0%
Holding current value
$2,855
Previous $3.95 Million
20.96%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.02 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$715 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$498 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$488 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...